Skip to main content

Table 4 Characteristics of responders and non-responders to treprostinil in echocardiography among preterm infants

From: Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension

 

GA (weeks)

Birthweight (gm)

Sex

Associated conditions

Treprostinil (PND)

Conditions at treprostinil start

Outcomes

Weight (g)

Mode of ventilator

RSS

Inhaled NO (ppm)

At 4 weeks

At discharge

Non-responder

34.7

2,540

Male

CDH

1

2,540

HFOV

9.8

70

Died

 

34

2,050

Male

CDH

7

2,430

HFOV

8

80

Died

 

31.1

1,210

Male

Down syndrome

73

2,620

HFOV

11

80

Died

 

23.6

660

Male

PPHN

11

920

HFOV

12.4

40

Died

 

27.4

1,140

Male

PPHN

4

1,440

HFOV

8.4

50

Survived

Survived

34.7

2,600

Female

PPHN

14

2,650

HFOV

13.6

80

Died

 

33.1

2,010

Male

PPHN, Potter sequence

1

2,010

HFOV

11.2

60

Died

 

28.4

390

Female

Severe BPD

314

7,350

HFOV

8.4

20

Survived

Survived

26.9

830

Female

Severe BPD

298

4,920

Conventional

13.6

11

Survived

Survived

24.9

770

Female

Severe BPD

39

1,460

HFOV

16

40

Survived

Survived

24.4

710

Male

Severe BPD

18

700

Conventional

12.4

80

Died

 

Responder

35.7

2,340

Male

CDH

10

2,900

HFOV

8.4

40

Survived

Died

30.6

600

Male

PPHN, Severe BPD

4

530

HFOV

6.2

40

Survived

Survived

24.9

700

Male

Severe BPD

19

850

Conventional

6

30

Survived

Died

24.4

690

Female

Severe BPD

32

890

HFOV

6.6

60

Survived

Survived

33.4

2,490

Female

Severe BPD

121

5,110

Conventional

12.9

60

Survived

Survived

30.9

740

Male

Severe BPD,

45

1,340

Conventional

18

40

Survived

Died

31.9

790

Male

EA, severe BPD, chylothorax

54

1,750

Conventional

16.1

80

Survived

Died

  1. GA, gestational age; PND, postnatal days; CDH, congenital diaphragmatic hernia; PPHN, persistent pulmonary hypertension; BPD, bronchopulmonary dysplasia; HFOV, high frequency oscillatory ventilation; EA, esophageal atresia